Answers are grounded in this paper and cite their sources.
Current medical device regulation is insufficient for addressing the unique features and evolving nature of AI technology, leaving gaps that regulators across the world are working to close. In this News and Perspectives article, JMIR Correspondent Tejas S Athni reports on a recently released report outlining 44 recommendations that, if implemented, could provide a more comprehensive, life cycle–based regulatory framework for health care AI in the United Kingdom.
No takes yet. Share an insight, caveat, or question.
Tejas S. Athni (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: